AzTrials
AzTrials

Metal Staple Removal After Total Knee ReplacementNCT02812602

Topical Anesthesia for Removal of Stitches After Total Knee Arthroplasty

A study testing Lidocaine patch in people with Metal Staple Removal After Total Knee Replacement, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Lidocaine patch is a safe and effective topical anesthetic agent for removal of metal staples after total knee replacement Read more about this study

Who is it for?
Ages 50 to 100 yearsHealthy volunteers can take part
What is being tested?
Lidocaine patch
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteTaiwan
Study dates
Apr 2016to Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Males and females, aged 50-100 years
  • The patients who undergo primary total knee replacement (performed by the same surgeon, Dr.Jiang)
  • Clear consciousness
  • No contraindication for staple removal on the post-operative day 7

Who cannot join

  • Allergy to lidocaine
  • Patient with second or third degree atrio-ventricular block
  • Patients with severe Sinoatrial node block
  • Patients taking class I antiarrhythmia drugs
  • Pregnant patients
  • Patients undergoing revision total knee replacement
  • Contraindication for removal of staples on post-operative day 7

Trial locations and contacts

1 site in 1 country.

Ching-Chuan Jiang contact

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei, Test2, test3

    Ching-Chuan Jiang, 886-2-23123456 ext. 65273, ccj@ntu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Topical Anesthesia With Lidocaine Patch for Removal of Metal Staples After Total Knee Arthroplasty: A Prospective Randomized Trial

Lidocaine patch is a safe and effective topical anesthetic agent for removal of metal staples after total knee replacement

Read the detailed description

This is a double-blind randomised control trial. After informed consent, the patients who undergoes primary total knee replacement will be assigned to either control group or experimental group randomly. The effectiveness and complication will be analysed.

If the patients are not medically fit for the study (including contraindications for lidocaine), they will be excluded.

Being tested
Lidocaine patch, placebo
Keywords
Total Knee Replacement, Stitch, Removal, Pain
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lidocaine patchDrug

    Lidocain patch will be applied around the surgical wound about 20 minutes before removal of staples.

  • placeboDrug

    Placebo patch will be applied around the surgical wound about 20 minutes before removal of staples.

Study groups in NCT02812602
Study groupRoleWhat they receive
Lidocaine patchExperimentalThe patients was randomly assigned to experimental group or placebo group. In this arm, lidocaine patches will be applied to the skin surrounding the surgical wound by one nurse practitioner. After more than 20 minutes the patch will be removed. Another nurse practitioner (double blinded) will remove the metal staples and record pain scale.
Receives: Drug: Lidocaine patch
PlaceboPlacebo comparatorThe patients was randomly assigned to experimental group or placebo group. In this arm, a placebo patch will be applied to the skin surrounding the surgical wound by one nurse practitioner. After more than 20 minutes the patch will be removed. Another nurse practitioner (double blinded) will remove the metal staples and record pain scale.
Receives: Drug: placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analog scale for pain

    The person who removes the staples evaluated the pain intensity. The pain intensity is evaluated with visual analog scale for pain

    Measured: 30min

Secondary outcomes (1)
  1. Complication rate of lidocaine patch

    The incidence of related complications after application of lidocaine patch

    Measured: Two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionJun 2016 (estimated)
  4. Study completionJun 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02812602
Sponsor's protocol ID
201505116MINA
Status last verified
Jun 2016
First submitted
17 Apr 2016
Last updated
24 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Lidocaine patch in people with Metal Staple Removal After Total Knee Replacement, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tzu-Hao Tseng (886-978326537, b92401004@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analog scale for pain (time frame: 30min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in